These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 29294304
1. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands. Gawel K, Jenda-Wojtanowska M, Gibula-Bruzda E, Kedzierska E, Filarowska J, Marszalek-Grabska M, Wojtanowski KK, Komsta L, Talarek S, Kotlinska JH. Physiol Behav; 2018 Mar 01; 185():112-120. PubMed ID: 29294304 [Abstract] [Full Text] [Related]
2. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats. Pałucha-Poniewiera A, Szewczyk B, Pilc A. Neuropharmacology; 2014 Jul 01; 82():59-68. PubMed ID: 24631968 [Abstract] [Full Text] [Related]
3. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus. Summa M, Di Prisco S, Grilli M, Usai C, Marchi M, Pittaluga A. Neuropharmacology; 2013 Mar 01; 66():215-24. PubMed ID: 22564442 [Abstract] [Full Text] [Related]
4. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Popik P, Kozela E, Pilc A. Br J Pharmacol; 2000 Jul 01; 130(6):1425-31. PubMed ID: 10903986 [Abstract] [Full Text] [Related]
5. Impact of the metabotropic glutamate receptor7 (mGlu7) allosteric agonist, AMN082, on fear learning and memory and anxiety-like behavior. Kotlinska JH, Lopatynska-Mazurek M, Gawel K, Gabka P, Jenda-Wojtanowska M, Kruk-Slomka M, Marszalek-Grabska M, Danilczuk Z, Kedzierska E, Talarek S, Listos J, Gibula-Tarlowska E. Eur J Pharmacol; 2019 Sep 05; 858():172512. PubMed ID: 31260653 [Abstract] [Full Text] [Related]
6. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Kozela E, Pilc A, Popik P. Psychopharmacology (Berl); 2003 Jan 05; 165(3):245-51. PubMed ID: 12442203 [Abstract] [Full Text] [Related]
7. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice. Jenda M, Gawel K, Marszalek M, Komsta L, Kotlinska JH. Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar 03; 57():166-75. PubMed ID: 25448778 [Abstract] [Full Text] [Related]
8. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats. Pałucha-Poniewiera A, Pilc A. Behav Brain Res; 2013 Feb 01; 238():109-12. PubMed ID: 23085340 [Abstract] [Full Text] [Related]
9. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice. Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A. Neuropharmacology; 2018 Oct 01; 141():214-222. PubMed ID: 30145321 [Abstract] [Full Text] [Related]
10. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Koltunowska D, Gibula-Bruzda E, Kotlinska JH. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():242-9. PubMed ID: 23623810 [Abstract] [Full Text] [Related]
11. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death. Domin H, Jantas D, Śmiałowska M. Neurochem Int; 2015 Sep 01; 88():110-23. PubMed ID: 25576184 [Abstract] [Full Text] [Related]
12. Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for Modulating Pain-evoked Activities of Neurons in the Hippocampal CA3 Region of Rats. Wei X, Yang D, Shi T, Wang J, Deng Y, Qiao X, Yang C, Xu M. CNS Neurol Disord Drug Targets; 2017 Sep 01; 16(5):610-616. PubMed ID: 27488423 [Abstract] [Full Text] [Related]
13. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain. Zhou Q, Wang J, Zhang X, Zeng L, Wang L, Jiang W. Eur J Pharmacol; 2013 Oct 15; 718(1-3):17-23. PubMed ID: 24041921 [Abstract] [Full Text] [Related]
14. Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning. Klakotskaia D, Ramsey AK, Fowler SW, Serfozo P, Simonyi A, Schachtman TR. Behav Brain Res; 2013 Sep 15; 253():9-16. PubMed ID: 23827202 [Abstract] [Full Text] [Related]
15. mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo. Gabra BH, Smith FL, Navarro HA, Carroll FI, Dewey WL. Brain Res; 2008 Jan 02; 1187():58-66. PubMed ID: 18022146 [Abstract] [Full Text] [Related]
16. AMN082-a metabotropic glutamate receptor type 7 allosteric agonist in the NAc facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats. Vatankhah M, Sarihi A, Komaki A, Shahidi S, Haghparast A. Brain Res Bull; 2018 Jun 02; 140():28-33. PubMed ID: 29605484 [Abstract] [Full Text] [Related]
17. Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal. Wang CC, Kuo JR, Huang SK, Wang SJ. Eur J Pharmacol; 2018 Mar 15; 823():11-18. PubMed ID: 29378190 [Abstract] [Full Text] [Related]
18. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM, Movsesyan VA, Faden AI. Br J Pharmacol; 2005 Jun 15; 145(4):527-34. PubMed ID: 15821750 [Abstract] [Full Text] [Related]
19. Role of spinal metabotropic glutamate receptor subtype 5 in the development of tolerance to morphine-induced antinociception in rat. Xu T, Jiang W, Du D, Xu Y, Hu Q, Shen Q. Neurosci Lett; 2007 Jun 13; 420(2):155-9. PubMed ID: 17512115 [Abstract] [Full Text] [Related]
20. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Rossi F, Maione S. Neuropharmacology; 2001 Mar 13; 40(3):319-26. PubMed ID: 11166324 [Abstract] [Full Text] [Related] Page: [Next] [New Search]